Intrinsic Edge Capital Management LLC Corcept Therapeutics Inc Transaction History
Intrinsic Edge Capital Management LLC
- $678 Million
- Q4 2024
A detailed history of Intrinsic Edge Capital Management LLC transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Intrinsic Edge Capital Management LLC holds 186,150 shares of CORT stock, worth $12.6 Million. This represents 1.38% of its overall portfolio holdings.
Number of Shares
186,150
Previous 186,150
-0.0%
Holding current value
$12.6 Million
Previous $8.61 Million
8.93%
% of portfolio
1.38%
Previous 1.1%
Shares
3 transactions
Others Institutions Holding CORT
# of Institutions
413Shares Held
84.9MCall Options Held
1.04MPut Options Held
1.33M-
Black Rock Inc. New York, NY16.5MShares$1.12 Billion0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$682 Million0.01% of portfolio
-
Ingalls & Snyder LLC New York, NY8.1MShares$546 Million16.01% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny6.2MShares$418 Million0.49% of portfolio
-
Parallel Advisors, LLC3.97MShares$268 Million5.04% of portfolio
About CORCEPT THERAPEUTICS INC
- Ticker CORT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,105,000
- Market Cap $7.22B
- Description
- Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...